Brand names: ZINPLAVA
Bezlotoxumab is indicated for:
Prevention of recurrence of Clostridium difficile infection (CDI)
Irrespective of gender only Adults (18 years old or older)
Bezlotoxumab is indicated for the prevention of recurrence of Clostridium difficile infection (CDI) in adults at high risk for recurrence of CDI.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 10 mg/kg once
Active ingredient Bezlotoxumab is contraindicated in the following cases: